Warburg Pincus-Led Investor Group Acquires Controlling Stake in PANTHERx Rare
A Warburg Pincus-led investor group has agreed to acquire a controlling interest in PANTHERx Rare, the leading independent rare pharmacy in the U.S., from Nautic Partners, General Atlantic, and The Vistria Group. This investment aims to support continued innovation in rare disease care while maintaining its patient-first model.
Topics: healthcare investment pharmacy rare diseases